Arno Therapeutics Stock Forecast, Price & News

0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Average Volume93,730 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. is based in Flemington, New Jersey.

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolOTCMKTS:ARNI
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.50 out of 5 stars

Medical Sector

1578th out of 2,011 stocks

Biotechnology Industry

87th out of 143 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ARNI News and Ratings via Email

Sign-up to receive the latest news and ratings for ARNI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Arno Therapeutics (OTCMKTS:ARNI) Frequently Asked Questions

What stocks does MarketBeat like better than Arno Therapeutics?

Wall Street analysts have given Arno Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Arno Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Arno Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Arno Therapeutics' stock was trading at $0.0030 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ARNI shares have increased by 166.7% and is now trading at $0.0080.
View which stocks have been most impacted by COVID-19

Who are Arno Therapeutics' key executives?

Arno Therapeutics' management team includes the following people:
  • Mr. David M. Tanen J.D., Sec. (Age 50)

Who are some of Arno Therapeutics' key competitors?

What other stocks do shareholders of Arno Therapeutics own?

What is Arno Therapeutics' stock symbol?

Arno Therapeutics trades on the OTCMKTS under the ticker symbol "ARNI."

How do I buy shares of Arno Therapeutics?

Shares of ARNI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Arno Therapeutics' stock price today?

One share of ARNI stock can currently be purchased for approximately $0.01.

How many employees does Arno Therapeutics have?

Arno Therapeutics employs 4 workers across the globe.

What is Arno Therapeutics' official website?

The official website for Arno Therapeutics is www.arnothera.com.

Where are Arno Therapeutics' headquarters?

Arno Therapeutics is headquartered at 200 State Route 31 Ste 104, FLEMINGTON, NJ 08822-5812, United States.

How can I contact Arno Therapeutics?

Arno Therapeutics' mailing address is 200 State Route 31 Ste 104, FLEMINGTON, NJ 08822-5812, United States. The company can be reached via phone at +1-862-7037175.

This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.